Cagrilintide 50mg — Vial Spec, Reconstitution Math & COA

Overview of Cagrilintide 50mg in High-Throughput Research

A 50mg vial of cagrilintide contains 50 milligrams of highly purified, lyophilized synthetic peptide, engineered as a long-acting non-selective amylin and calcitonin receptor agonist for preclinical investigation. In molecular biology and preclinical pharmacology, this high-mass format is predominantly requested by institutional laboratories executing large-scale, automated screening assays or longitudinal rodent models requiring consistent dosing across extended operational schedules.

By utilizing a single high-capacity 50mg vial, investigators can eliminate lot-to-lot variability across extended experimental series. Rather than opening multiple lower-mass vials over time, a single master reconstitution protocol can be established to supply working stock for hundreds of microtiter plates or large animal cohorts. Researchers exploring receptor cross-reactivity, signal transduction kinetics, or comparative metabolic pathways frequently utilize cagrilintide in conjunction with other metabolic research compounds listed across our all peptides catalog.

Mass, Format Availability, and PX1 Research Standards

PX1 Research primary inventory maintains cagrilintide in standard single-study mass specifications, such as 5mg and 10mg lyophilized formats, which are directly accessible on our primary cagrilintide product page. However, high-throughput academic laboratories, core facilities, and contract research organizations (CROs) frequently require high-mass formulations such as 50mg to meet elevated consumption demands.

When laboratories require bulk quantities or high-mass single vials like cagrilintide 50mg, PX1 Research provides specialized procurement protocols via our wholesale accounts division. Every fill size—whether a standard 5mg vial or a custom-filled 50mg high-mass vial—is manufactured in USA-based, GMP-compliant facilities and undergoes identical ISO 17025 analytical testing to ensure complete chemical purity and structural identity.

Reconstitution Math: Diluent Volumes and Stock Concentrations

Reconstituting a 50mg vial of cagrilintide requires accurate calculation of diluent volume relative to the desired working concentration. Because 50 milligrams represents a substantial mass of peptide powder, investigators must ensure adequate diluent volume to achieve full dissolution without exceeding target concentration limits or causing steric precipitation.

When adding 1.0 mL of reconstituting medium (such as sterile bacteriostatic water or target-adjusted buffer) to a 50mg lyophilized cake, the resulting stock concentration is precisely 50.0 mg/mL (or 50.0 µg/µL). This hyper-concentrated stock is ideal for minimal-volume micro-dosing protocols or cryogenic storage of master stocks.

When adding 2.0 mL of diluent to a 50mg vial, the resulting stock concentration yields 25.0 mg/mL (25.0 µg/µL). This intermediate concentration balances rapid liquid transfer with manageable pipetting volumes for high-throughput screening assays.

When adding 3.0 mL of diluent to a 50mg vial, the working concentration becomes 16.67 mg/mL (16.67 µg/µL). Higher diluent volumes lower liquid viscosity and enhance dissolution kinetics, making 3.0 mL ideal when handling automated fluid-dispensing robotics. To model custom concentrations or alternate diluent volumes, researchers should utilize our interactive reconstitution calculator.

Aliquot Planning and Cryogenic Storage Protocol

Because repeated freeze-thaw cycles induce peptide shear, aggregation, and physical degradation, high-mass 50mg reconstituted stock solutions should never be stored in a single primary container for repeated aspiration. Immediately following complete solubilization, the master solution must be aliquoted into single-use, low-binding polypropylene micro-centrifuge tubes.

For example, a 50mg vial reconstituted with 2.0 mL of diluent (25 mg/mL) can be divided into twenty 100 µL aliquots, each containing 2.5 mg of active cagrilintide compound. Aliquots designated for immediate use within 24 to 48 hours may be held at 2°C to 8°C. For long-term preservation across multi-month experimental timelines, working aliquots must be flash-frozen and maintained at -20°C or -80°C in non-frost-free freezer units.

Prior to experimental deployment, individual sub-aliquots should be thawed slowly on ice. Any unused portion of a thawed working aliquot should be discarded at the conclusion of the assay day rather than re-frozen, preserving quantitative integrity across all assay replicates.

Analytical Verification: Lot-Matched COA, HPLC, and Endotoxin Testing

To guarantee reproducibility across sensitive in vitro cellular assays and animal models, every batch of cagrilintide synthesized for PX1 Research undergoes stringent multi-stage analytical testing. Independent ISO 17025 accredited laboratories evaluate every lot using High-Performance Liquid Chromatography (HPLC) to confirm chemical purity exceeding 99.0%.

Mass Spectrometry (MS) analysis is performed concurrently to verify the precise molecular mass and primary amino acid sequence match, ruling out truncated fragments or synthesis side-products. Furthermore, because bacterial endotoxins interfere with cell viability and inflammatory signaling cascades, every lot undergoes Chromogenic LAL testing to verify endotoxin levels remain strictly below < 0.01 EU/mg.

Principal investigators can review or download complete analytical documentation for their specific lot directly via our centralized COA verification hub. Each Certificate of Analysis details the observed purity profile, mass spectrum, synthesis batch number, and expiration parameter.

Selecting Optimal Vial Mass: 50mg vs. Standard Research Quantities

Selecting the correct peptide mass configuration depends entirely on the scope, duration, and automation requirements of the underlying research protocol. While a 50mg vial offers unit-cost efficiency and batch uniformity for high-throughput operational scales, smaller formats offer distinct handling advantages for exploratory or lower-volume studies.

For small-scale pilot studies, binding affinity assays, or preliminary solubility screens, smaller mass units such as 5mg or 10mg vials are typically preferable. Standard sizes minimize reconstituted solution volume, reducing the risk of long-term storage degradation if an assay series is suspended. Conversely, when executing automated high-content cell imaging or longitudinal rodent cohorts, a 50mg vial ensures that the identical stock solution powers the entire trial from baseline through terminal data collection.

Investigators seeking to compare parameter requirements across various project scales can consult our comprehensive research hub to examine standardized methodological methodologies and peptide handling protocols.

Comparative Analysis: Amylin Agonists and Incretin Co-Agonists

In preclinical metabolic investigation, cagrilintide represents a distinct class of non-selective amylin and calcitonin receptor agonists (AMYR/CTR). To fully map metabolic signaling networks, investigators frequently run comparative studies involving complementary peptide classes that target distinct G-protein coupled receptors.

Preclinical models regularly evaluate cagrilintide alongside mono-GLP-1 receptor agonists like semaglutide, dual GIP/GLP-1 receptor agonists such as tirzepatide, and triple GIP/GLP-1/Glucagon receptor agonists such as retatrutide. While incretin mimetics act primarily through intestinal signaling axes, amylin receptor agonists engage central homeostatic signaling circuits within the area postrema and nucleus of the solitary tract. Combining or contrasting these distinct molecular pathways in laboratory settings allows researchers to elucidate synergistic neuro-hormonal control mechanisms.

Solubilization Handling and pH Buffer Considerations

Reconstituting a dense 50mg peptide cake requires rigorous physical handling technique. The diluent should be introduced slowly along the glass wall of the vial, allowing the liquid to gently cascade over the lyophilized material. Direct high-pressure injection into the center of the cake must be avoided, as it can cause localized foaming and protein shear.

The vial should be gently swirled or rolled between the palms until the solution becomes completely clear and transparent. Swirling should continue until no suspended particles or refractile threads remain visible under bright laboratory lighting. Mechanical vortexing or vigorous shaking is strictly contraindicated, as high shear forces can disrupt secondary molecular folding.

While sterile bacteriostatic water (containing 0.9% benzyl alcohol) is suitable for most multi-dose laboratory applications, specific cellular assays sensitive to preservative agents may require sterile 0.9% sodium chloride or phosphate-buffered saline (PBS, pH 7.4). Solubilization characteristics should always be validated in pilot volumes prior to diluting the entire 50mg mass.

Procurement, Supply Chain, and Dispatch Standards

PX1 Research maintains complete physical control of its inventory through state-of-the-art dispatch facilities operating in California and Arizona. All research compounds, including specialized high-mass peptide offerings, are stored in temperature-monitored, sub-zero environments prior to packaging.

Orders placed Monday through Friday before cut-off schedules receive same-day dispatch, ensuring minimal transit exposure and rapid delivery to institutional research labs. Secure packaging protects delicate glass vials from physical shock and temperature spikes during transport, guaranteeing that the high-purity compound arrives ready for immediate laboratory preparation and analytical use.